|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 208 of 212 found articles
| Title: |
122TiP Phase III study of durvalumab with SBRT for unresected stage I/II, lymph-node negative NSCLC (PACIFIC-4/RTOG 3515) |
| Author: |
Robinson, C. Xing, L. Tanaka, H. Tasaka, S. Badiyan, S.N. Nasrallah, H. Biswas, T. Shtivelband, M. Schuette, W. Shi, A. Hepner, A. Barrett, K. Rigas, J.R. Jiang, H. Lin, S.H. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. S2 pages S88 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 208 of 212 found articles
| << previous | next >> |